2-238251757-T-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_022817.3(PER2):āc.3116A>Gā(p.Asp1039Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000878 in 1,583,424 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_022817.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PER2 | NM_022817.3 | c.3116A>G | p.Asp1039Gly | missense_variant | 20/23 | ENST00000254657.8 | NP_073728.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PER2 | ENST00000254657.8 | c.3116A>G | p.Asp1039Gly | missense_variant | 20/23 | 1 | NM_022817.3 | ENSP00000254657.3 | ||
PER2 | ENST00000707129.1 | c.3116A>G | p.Asp1039Gly | missense_variant | 20/23 | ENSP00000516757.1 | ||||
PER2 | ENST00000707130.1 | c.3116A>G | p.Asp1039Gly | missense_variant | 20/23 | ENSP00000516758.1 | ||||
ENSG00000225057 | ENST00000456601.1 | n.1525-2431T>C | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000477 AC: 7AN: 146636Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000557 AC: 14AN: 251436Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135910
GnomAD4 exome AF: 0.0000919 AC: 132AN: 1436708Hom.: 1 Cov.: 34 AF XY: 0.0000769 AC XY: 55AN XY: 714786
GnomAD4 genome AF: 0.0000477 AC: 7AN: 146716Hom.: 0 Cov.: 31 AF XY: 0.0000845 AC XY: 6AN XY: 71030
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 01, 2024 | The c.3116A>G (p.D1039G) alteration is located in exon 20 (coding exon 19) of the PER2 gene. This alteration results from a A to G substitution at nucleotide position 3116, causing the aspartic acid (D) at amino acid position 1039 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at